About Sanofi-Aventis Administrative Office
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sanofi
44
Clinical Trials at Sanofi-Aventis Administrative Office
During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
2001-04-01
2014-12-01
Completed
3,222
Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
2002-10-01
2005-08-01
Completed
15,603
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
2003-08-01
2011-12-01
Completed
12,537
Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
2002-10-01
2006-12-01
Completed
20,506
Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment
2004-08-01
2009-04-01
Completed
168
Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis
2004-09-01
2010-07-01
Completed
1,088
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office"
#1 collaborator was "Bristol-Myers Squibb" with 6 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Groupe Oncologie Radiotherapie Tete et Cou" with 1 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Sanofi-Aventis Administrative Office
According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are
"Atrial Fibrillation" (6 trials), "Breast Neoplasms" (3 trials), "Diabetes Mellitus, Type 2" (3 trials), "Obesity" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.
Clinical Trials Intervention Types at Sanofi-Aventis Administrative Office
Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (41 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Rimonabant" (4 trials), "placebo" (4 trials), "Placebo (for Rimonabant)" (3 trials) and "Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Sanofi-Aventis Administrative Office
The vast majority of trials in "Sanofi-Aventis Administrative Office" are
39 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Sanofi-Aventis Administrative Office
Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 37 completed trials in Sanofi-Aventis Administrative Office,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 0 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 33 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".